KEVIN HUNG NGUYEN
Nail Technician in Philadelphia, PA
License number
Pennsylvania CL017188L
Category
Cosmetology
Type
Nail Technician
Address
Address
Philadelphia, PA 19124
Professional information
Pharmaceuticals Professional
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Work:
Merck & Co., Inc.
2006 - 2009
-
Research associate
Merck & Co., Inc.
2006 - 2009
-
research associate
Developer At Wilmington Trust
Position:
Developer at Wilmington Trust
Location:
Greater Philadelphia Area
Industry:
Computer Software
Work:
Wilmington Trust
-
Developer
Education:
Drexel University 2000 - 2003
Accounting Professional
Location:
Greater Philadelphia Area
Industry:
Accounting
Kevin Nguyen
Location:
Greater Philadelphia Area
Industry:
Computer Software
Kevin Nguyen
Location:
Greater Philadelphia Area
Industry:
Computer Software
N-Substituted Nonaryl-Heterocyclic Nmda/Nr2B Antagonists
US Patent:
7217716, May 15, 2007
Filed:
Feb 20, 2002
Appl. No.:
10/470561
Inventors:
Christopher F. Claiborne - Cambridge MA, US
David A. Claremon - Maple Glen PA, US
Brian E. Libby - Noblesville IN, US
John W. Butcher - Telford PA, US
John A. McCauley - Maple Glen PA, US
Nigel J. Liverton - Harleysville PA, US
Peter M. Munson - Harleysville PA, US
Kevin T. Nguyen - Philadelphia PA, US
Brian Phillips - Telford PA, US
Wayne Thompson - Landsdale PA, US
David A. Claremon - Maple Glen PA, US
Brian E. Libby - Noblesville IN, US
John W. Butcher - Telford PA, US
John A. McCauley - Maple Glen PA, US
Nigel J. Liverton - Harleysville PA, US
Peter M. Munson - Harleysville PA, US
Kevin T. Nguyen - Philadelphia PA, US
Brian Phillips - Telford PA, US
Wayne Thompson - Landsdale PA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D 401/12, A61K 31/444
US Classification:
5142632, 5142634, 514275, 514304, 544277, 544330, 546124, 546125, 546126
Abstract:
Compounds represented by Formula (I): (I) or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.
Compounds Having Cytokine Inhibitory Activity
US Patent:
6291457, Sep 18, 2001
Filed:
Jun 19, 2000
Appl. No.:
9/596563
Inventors:
Christopher F. Claiborne - Lansdale PA
David A. Claremon - Maple Glen PA
Nigel J. Liverton - Harleysville PA
Kevin T. Nguyen - Philadelphia PA
David A. Claremon - Maple Glen PA
Nigel J. Liverton - Harleysville PA
Kevin T. Nguyen - Philadelphia PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 315377, A61P 1908, C07D41314
US Classification:
5142358
Abstract:
There are disclosed compounds of formula (I) ##STR1##
and pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.
N-Substituted Nonaryl-Heterocyclic Nmda/Nr2B Antagonists
US Patent:
7053089, May 30, 2006
Filed:
Feb 20, 2002
Appl. No.:
10/079452
Inventors:
Christopher F. Claiborne - Cambridge MA, US
John W. Butcher - Telford PA, US
David A. Claremon - Maple Glen PA, US
Brian E. Libby - Noblesville IN, US
Nigel J. Liverton - Harleysville PA, US
Peter M. Munson - Harleysville PA, US
Kevin T. Nguyen - Philadelphia PA, US
Brian Phillips - Telford PA, US
Wayne Thompson - Lansdale PA, US
John A. McCauley - Maple Glen PA, US
John W. Butcher - Telford PA, US
David A. Claremon - Maple Glen PA, US
Brian E. Libby - Noblesville IN, US
Nigel J. Liverton - Harleysville PA, US
Peter M. Munson - Harleysville PA, US
Kevin T. Nguyen - Philadelphia PA, US
Brian Phillips - Telford PA, US
Wayne Thompson - Lansdale PA, US
John A. McCauley - Maple Glen PA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D 401/12, C07D 403/12, A61K 31/4545
US Classification:
51425203, 51425505, 514256, 51426322, 514275, 514318, 514322, 514326, 544238, 544264, 544328, 544329, 544330, 544331, 544332, 544336, 544409, 546194, 546208, 546209
Abstract:
Compounds represented by Formula (I):.